Role of FGF/FGFR signaling in skeletal development and homeostasis: learning from mouse models

[1]  E. Farrow,et al.  Neonatal Iron Deficiency Causes Abnormal Phosphate Metabolism by Elevating FGF23 in Normal and ADHR Mice , 2014, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[2]  S. Sardiwal,et al.  Bone alkaline phosphatase in CKD-mineral bone disorder. , 2013, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[3]  S. Kliewer,et al.  FGF21 contributes to neuroendocrine control of female reproduction , 2013, Nature Medicine.

[4]  M. Egerbacher,et al.  Fibroblast Growth Factor 23 and Klotho Are Present in the Growth Plate , 2013, Connective tissue research.

[5]  Liping Xiao,et al.  Nuclear fibroblast growth factor 2 (FGF2) isoforms inhibit bone marrow stromal cell mineralization through FGF23/FGFR/MAPK in vitro , 2013, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[6]  C. Deng,et al.  A novel FGFR3-binding peptide inhibits FGFR3 signaling and reverses the lethal phenotype of mice mimicking human thanatophoric dysplasia. , 2012, Human molecular genetics.

[7]  N. Bhattacharyya,et al.  Fibroblast growth factor 23: state of the field and future directions , 2012, Trends in Endocrinology & Metabolism.

[8]  M. Hurley,et al.  Role of fibroblast growth factor 2 and wnt signaling in anabolic effects of parathyroid hormone on bone formation , 2012, Journal of cellular physiology.

[9]  C. Deng,et al.  Intermittent PTH (1-34) injection rescues the retarded skeletal development and postnatal lethality of mice mimicking human achondroplasia and thanatophoric dysplasia. , 2012, Human molecular genetics.

[10]  A. Flenniken,et al.  A novel Phex mutation in a new mouse model of hypophosphatemic rickets , 2012, Journal of cellular biochemistry.

[11]  Shuai Li,et al.  Fibroblast Growth Factor 13 Is a Microtubule-Stabilizing Protein Regulating Neuronal Polarization and Migration , 2012, Cell.

[12]  I. Rosewell,et al.  Fibroblast Growth Factor 22 Is Not Essential for Skin Development and Repair but Plays a Role in Tumorigenesis , 2012, PloS one.

[13]  F. De Luca,et al.  Fibroblast Growth Factor 21 (FGF21) Inhibits Chondrocyte Function and Growth Hormone Action Directly at the Growth Plate , 2012, The Journal of Biological Chemistry.

[14]  R. Salomon,et al.  FGF9 and FGF20 maintain the stemness of nephron progenitors in mice and man. , 2012, Developmental cell.

[15]  J. Richtsmeier,et al.  p38 Inhibition ameliorates skin and skull abnormalities in Fgfr2 Beare-Stevenson mice. , 2012, The Journal of clinical investigation.

[16]  Masashi Suzuki,et al.  Hair cycle resting phase is regulated by cyclic epithelial FGF18 signaling. , 2012, The Journal of investigative dermatology.

[17]  P. Marie,et al.  FGF/FGFR signaling in bone formation: Progress and perspectives , 2012, Growth factors.

[18]  F. Cantatore,et al.  Osteocytes: central conductors of bone biology in normal and pathological conditions , 2012, Acta physiologica.

[19]  F. De Luca,et al.  Role of fibroblast growth factor 21 (FGF21) in undernutrition-related attenuation of growth in mice. , 2012, Endocrinology.

[20]  S. Kliewer,et al.  Fibroblast growth factor 21 promotes bone loss by potentiating the effects of peroxisome proliferator-activated receptor γ , 2012, Proceedings of the National Academy of Sciences.

[21]  G. Karsenty,et al.  The contribution of bone to whole-organism physiology , 2012, Nature.

[22]  L. Quarles,et al.  Skeletal secretion of FGF-23 regulates phosphate and vitamin D metabolism , 2012, Nature Reviews Endocrinology.

[23]  Jason R. Stubbs,et al.  Longitudinal evaluation of FGF23 changes and mineral metabolism abnormalities in a mouse model of chronic kidney disease , 2012, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[24]  A. Go,et al.  FGF23 induces left ventricular hypertrophy. , 2011, The Journal of clinical investigation.

[25]  E. Farrow,et al.  Iron deficiency drives an autosomal dominant hypophosphatemic rickets (ADHR) phenotype in fibroblast growth factor-23 (Fgf23) knock-in mice , 2011, Proceedings of the National Academy of Sciences.

[26]  G. Karsenty.  Bone endocrine regulation of energy metabolism and male reproduction. , 2011, Comptes rendus biologies.

[27]  W. Sellers,et al.  FGF receptors control vitamin D and phosphate homeostasis by mediating renal FGF‐23 signaling and regulating FGF‐23 expression in bone , 2011, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[28]  Leah R. Padgett,et al.  Iron modifies plasma FGF23 differently in autosomal dominant hypophosphatemic rickets and healthy humans. , 2011, The Journal of clinical endocrinology and metabolism.

[29]  Liping Xiao,et al.  The impaired bone anabolic effect of PTH in the absence of endogenous FGF2 is partially due to reduced ATF4 expression. , 2011, Biochemical and biophysical research communications.

[30]  J. Adamski,et al.  The Pathologic Effect of a Novel Neomorphic Fgf9Y162C Allele Is Restricted to Decreased Vision and Retarded Lens Growth , 2011, PloS one.

[31]  Jian Q. Feng,et al.  Bone proteins PHEX and DMP1 regulate fibroblastic growth factor Fgf23 expression in osteocytes through a common pathway involving FGF receptor (FGFR) signaling , 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[32]  M. Longaker,et al.  Fgf-18 is required for osteogenesis but not angiogenesis during long bone repair. , 2011, Tissue engineering. Part A.

[33]  L. Quarles,et al.  The bone and beyond: 'Dem bones' are made for more than walking , 2011, Nature Medicine.

[34]  M. Sabbieti,et al.  Signaling pathways implicated in PGF2α effects on Fgf2+/+ and Fgf2−/− osteoblasts , 2010, Journal of cellular physiology.

[35]  T. Doetschman,et al.  Disruption of the Fgf2 gene activates the adipogenic and suppresses the osteogenic program in mesenchymal marrow stromal stem cells. , 2010, Bone.

[36]  Xiaoling Xu,et al.  Generation of Fgfr3 Conditional Knockout Mice , 2010, International journal of biological sciences.

[37]  M. Longaker,et al.  Fgf-9 is required for angiogenesis and osteogenesis in long bone repair , 2010, Proceedings of the National Academy of Sciences.

[38]  M. A. Sutton,et al.  Distinct FGFs promote differentiation of excitatory and inhibitory synapses , 2010, Nature.

[39]  A. Flenniken,et al.  The missense mutation W290R in Fgfr2 causes developmental defects from aberrant IIIb and IIIc signaling , 2010, Developmental dynamics : an official publication of the American Association of Anatomists.

[40]  Xiaofen Wang,et al.  FGF signaling regulates otic placode induction and refinement by controlling both ectodermal target genes and hindbrain Wnt8a. , 2010, Developmental biology.

[41]  Di Chen,et al.  Gain-of-function mutation in FGFR3 in mice leads to decreased bone mass by affecting both osteoblastogenesis and osteoclastogenesis. , 2010, Human molecular genetics.

[42]  C. Galli,et al.  Osteocytes and WNT: the Mechanical Control of Bone Formation , 2010, Journal of dental research.

[43]  J. Richtsmeier,et al.  Activation of p38 MAPK pathway in the skull abnormalities of Apert syndrome Fgfr2+P253R mice , 2010, BMC Developmental Biology.

[44]  A. Ullrich,et al.  A single nucleotide change in the mouse genome accelerates breast cancer progression. , 2010, Cancer research.

[45]  Yue Shen,et al.  Fibroblast growth factor receptor 1 regulates the differentiation and activation of osteoclasts through Erk1/2 pathway. , 2009, Biochemical and biophysical research communications.

[46]  H. Melhus,et al.  Serum intact FGF23 associate with left ventricular mass, hypertrophy and geometry in an elderly population. , 2009, Atherosclerosis.

[47]  Liping Xiao,et al.  Nuclear Isoforms of Fibroblast Growth Factor 2 Are Novel Inducers of Hypophosphatemia via Modulation of FGF23 and KLOTHO* , 2009, The Journal of Biological Chemistry.

[48]  J. Flier,et al.  Fibroblast growth factor 21-deficient mice demonstrate impaired adaptation to ketosis. , 2009, Endocrinology.

[49]  M. Konishi,et al.  Fibroblast growth factor 21 regulates lipolysis in white adipose tissue but is not required for ketogenesis and triglyceride clearance in liver. , 2009, Endocrinology.

[50]  Wei Huang,et al.  Multiple synostoses syndrome is due to a missense mutation in exon 2 of FGF9 gene. , 2009, American journal of human genetics.

[51]  I. Reid,et al.  Actions of fibroblast growth factor-8 in bone cells in vitro. , 2009, American journal of physiology. Endocrinology and metabolism.

[52]  S. Kliewer,et al.  FGF21 induces PGC-1α and regulates carbohydrate and fatty acid metabolism during the adaptive starvation response , 2009, Proceedings of the National Academy of Sciences.

[53]  Thomas J. Wang,et al.  Fibroblast Growth Factor 23 and Left Ventricular Hypertrophy in Chronic Kidney Disease , 2009, Circulation.

[54]  T. Doetschman,et al.  Endogenous FGF‐2 is critically important in PTH anabolic effects on bone , 2009, Journal of cellular physiology.

[55]  M. Takagi,et al.  FGF8 regulates myogenesis and induces Runx2 expression and osteoblast differentiation in cultured cells , 2009, Journal of cellular biochemistry.

[56]  A. Munnich,et al.  Activating Fgfr3 Y367C mutation causes hearing loss and inner ear defect in a mouse model of chondrodysplasia. , 2009, Biochimica et biophysica acta.

[57]  Gillian M Morriss-Kay,et al.  Skeletal analysis of the Fgfr3P244R mouse, a genetic model for the Muenke craniosynostosis syndrome , 2009, Developmental dynamics : an official publication of the American Association of Anatomists.

[58]  M. Yin,et al.  Gene targeted ablation of high molecular weight fibroblast growth factor‐2 , 2009, Developmental dynamics : an official publication of the American Association of Anatomists.

[59]  T. Doetschman,et al.  Exported 18-kDa Isoform of Fibroblast Growth Factor-2 Is a Critical Determinant of Bone Mass in Mice* , 2009, Journal of Biological Chemistry.

[60]  Makoto Taiji,et al.  FGF9 monomer/dimer equilibrium regulates extracellular matrix affinity and tissue diffusion , 2009, Nature Genetics.

[61]  A. Kawanami,et al.  FGFR3 promotes synchondrosis closure and fusion of ossification centers through the MAPK pathway. , 2008, Human molecular genetics.

[62]  K. Nakao,et al.  Fgf16 is required for cardiomyocyte proliferation in the mouse embryonic heart , 2008, Developmental dynamics : an official publication of the American Association of Anatomists.

[63]  Su-jin Kim,et al.  Fibroblast growth factor-2 and -4 promote the proliferation of bone marrow mesenchymal stem cells by the activation of the PI3K-Akt and ERK1/2 signaling pathways. , 2008, Stem cells and development.

[64]  T. Suda,et al.  Role of fibroblast growth factor 8 (FGF8) in animal models of osteoarthritis , 2008, Arthritis research & therapy.

[65]  L. Mucke,et al.  Abnormal social behaviors in mice lacking Fgf17 , 2008, Genes, brain, and behavior.

[66]  Xiaoling Xu,et al.  A Pro253Arg mutation in fibroblast growth factor receptor 2 (Fgfr2) causes skeleton malformation mimicking human Apert syndrome by affecting both chondrogenesis and osteogenesis. , 2008, Bone.

[67]  N. Itoh,et al.  Functional evolutionary history of the mouse Fgf gene family , 2008, Developmental dynamics : an official publication of the American Association of Anatomists.

[68]  G. Mundy.  Osteoporosis and inflammation. , 2007, Nutrition reviews.

[69]  R. Solaro,et al.  Protein Kinase C ζ , 2007, Journal of Biological Chemistry.

[70]  Tracy J. Wright,et al.  Fgf3 is required for dorsal patterning and morphogenesis of the inner ear epithelium , 2007, Development.

[71]  W. Fraser,et al.  The association of circulating ferritin with serum concentrations of fibroblast growth factor-23 measured by three commercial assays , 2007, Annals of clinical biochemistry.

[72]  Yongyou Zhang,et al.  Generation of an Frs2α conditional null allele , 2007 .

[73]  X. Coumoul,et al.  RNA interference and inhibition of MEK-ERK signaling prevent abnormal skeletal phenotypes in a mouse model of craniosynostosis , 2007, Nature Genetics.

[74]  G. Matthews,et al.  Fibroblast Growth Factor Homologous Factors Control Neuronal Excitability through Modulation of Voltage-Gated Sodium Channels , 2007, Neuron.

[75]  D. Ornitz,et al.  FGF9 regulates early hypertrophic chondrocyte differentiation and skeletal vascularization in the developing stylopod. , 2007, Developmental biology.

[76]  Hiroyuki Tanaka,et al.  PTH has the potential to rescue disturbed bone growth in achondroplasia. , 2007, Bone.

[77]  S. Kliewer,et al.  Endocrine regulation of the fasting response by PPARalpha-mediated induction of fibroblast growth factor 21. , 2007, Cell metabolism.

[78]  J. Aubin,et al.  Mineralized tissue cells are a principal source of FGF23. , 2007, Bone.

[79]  C. Heike,et al.  Syndromic craniosynostosis: from history to hydrogen bonds. , 2007, Orthodontics & craniofacial research.

[80]  V. P. Eswarakumar,et al.  Skeletal overgrowth is mediated by deficiency in a specific isoform of fibroblast growth factor receptor 3 , 2007, Proceedings of the National Academy of Sciences.

[81]  S. Kliewer,et al.  Molecular Insights into the Klotho-Dependent, Endocrine Mode of Action of Fibroblast Growth Factor 19 Subfamily Members , 2007, Molecular and Cellular Biology.

[82]  J. Baron,et al.  Fibroblast growth factor expression in the postnatal growth plate. , 2007, Bone.

[83]  D. Ornitz,et al.  FGF18 is required for early chondrocyte proliferation, hypertrophy and vascular invasion of the growth plate. , 2007, Developmental biology.

[84]  Ramon Bragós,et al.  FGF-4 increases in vitro expansion rate of human adult bone marrow-derived mesenchymal stem cells , 2007, Growth factors.

[85]  V. P. Eswarakumar,et al.  Attenuation of signaling pathways stimulated by pathologically activated FGF-receptor 2 mutants prevents craniosynostosis , 2006, Proceedings of the National Academy of Sciences.

[86]  L. Bonewald,et al.  Loss of DMP1 causes rickets and osteomalacia and identifies a role for osteocytes in mineral metabolism , 2006, Nature Genetics.

[87]  T. Strom,et al.  DMP1 mutations in autosomal recessive hypophosphatemia implicate a bone matrix protein in the regulation of phosphate homeostasis , 2006, Nature Genetics.

[88]  J. Partanen,et al.  Fibroblast growth factor receptor 1 signaling in the osteo-chondrogenic cell lineage regulates sequential steps of osteoblast maturation. , 2006, Developmental biology.

[89]  Xi Jiang,et al.  Pathogenic role of Fgf23 in Hyp mice. , 2006, American journal of physiology. Endocrinology and metabolism.

[90]  M. Razzaque,et al.  Hypervitaminosis D and premature aging: lessons learned from Fgf23 and Klotho mutant mice. , 2006, Trends in molecular medicine.

[91]  E. Quenneville,et al.  Defects in articular cartilage metabolism and early arthritis in fibroblast growth factor receptor 3 deficient mice. , 2006, Human molecular genetics.

[92]  P. Härkönen,et al.  Regulation of osteoblast differentiation: a novel function for fibroblast growth factor 8. , 2006, Endocrinology.

[93]  Fen Wang,et al.  Generation of an Fgf9 conditional null allele , 2006, Genesis.

[94]  P. Overbeek,et al.  FGF9 can induce endochondral ossification in cranial mesenchyme , 2006, BMC Developmental Biology.

[95]  Philippe Soriano,et al.  Context-specific requirements for Fgfr1 signaling through Frs2 and Frs3 during mouse development , 2006, Development.

[96]  I. Kalajzic,et al.  In vivo and in vitro comparison of the effects of FGF-2 null and haplo-insufficiency on bone formation in mice. , 2006, Biochemical and biophysical research communications.

[97]  B. Riggs,et al.  The role of the immune system in the pathophysiology of osteoporosis , 2005, Immunological reviews.

[98]  M. Hurley,et al.  FGF and FGFR signaling in chondrodysplasias and craniosynostosis , 2005, Journal of cellular biochemistry.

[99]  C. Deng,et al.  FGFR1 function at the earliest stages of mouse limb development plays an indispensable role in subsequent autopod morphogenesis , 2005, Development.

[100]  S. Kliewer,et al.  Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis. , 2005, Cell metabolism.

[101]  Y. Takeuchi,et al.  A novel mutation in fibroblast growth factor 23 gene as a cause of tumoral calcinosis. , 2005, The Journal of clinical endocrinology and metabolism.

[102]  Jamie M. Verheyden,et al.  Conditional inactivation of Fgfr1 in mouse defines its role in limb bud establishment, outgrowth and digit patterning , 2005, Development.

[103]  M. Lewandoski,et al.  Inactivation of FGF8 in early mesoderm reveals an essential role in kidney development , 2005, Development.

[104]  Fan Yang,et al.  Abnormalities in cartilage and bone development in the Apert syndrome FGFR2+/S252W mouse , 2005, Development.

[105]  K. White,et al.  Fibroblast Growth Factor 23 and Its Receptors , 2005, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.

[106]  X. Coumoul,et al.  Conditional knockdown of Fgfr2 in mice using Cre-LoxP induced RNA interference , 2005, Nucleic acids research.

[107]  K. Nakao,et al.  Complementary antagonistic actions between C-type natriuretic peptide and the MAPK pathway through FGFR-3 in ATDC5 cells. , 2005, Bone.

[108]  J. Gromada,et al.  FGF-21 as a novel metabolic regulator. , 2005, The Journal of clinical investigation.

[109]  C. Deng,et al.  Roles of FGF signaling in skeletal development and human genetic diseases. , 2005, Frontiers in bioscience : a journal and virtual library.

[110]  M. Ito,et al.  Over‐expression of fibroblast growth factor‐2 causes defective bone mineralization and osteopenia in transgenic mice , 2005, Journal of cellular biochemistry.

[111]  D. Ornitz,et al.  FGF signaling in the developing endochondral skeleton. , 2005, Cytokine & growth factor reviews.

[112]  V. P. Eswarakumar,et al.  Cellular signaling by fibroblast growth factor receptors. , 2005, Cytokine & growth factor reviews.

[113]  S. Mooney,et al.  A novel recessive mutation in fibroblast growth factor-23 causes familial tumoral calcinosis. , 2005, The Journal of clinical endocrinology and metabolism.

[114]  A. Wilkie.  Bad bones, absent smell, selfish testes: the pleiotropic consequences of human FGF receptor mutations. , 2005, Cytokine & growth factor reviews.

[115]  T. Clemens,et al.  Co-ordination of TGF-β and FGF signaling pathways in bone organ cultures , 2005, Mechanisms of Development.

[116]  P. Orlik,et al.  An FGF23 missense mutation causes familial tumoral calcinosis with hyperphosphatemia. , 2005, Human molecular genetics.

[117]  K. White,et al.  Mutations that cause osteoglophonic dysplasia define novel roles for FGFR1 in bone elongation. , 2005, American journal of human genetics.

[118]  R. Kirschner,et al.  Effects of FGF-2/-9 in calvarial bone cell cultures: differentiation stage-dependent mitogenic effect, inverse regulation of BMP-2 and noggin, and enhancement of osteogenic potential. , 2005, Bone.

[119]  C. Deng,et al.  [Gly374Arg mutation in Fgfr3 causes achondroplasia in mice]. , 2004, Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics.

[120]  M. Razzaque,et al.  Homozygous ablation of fibroblast growth factor-23 results in hyperphosphatemia and impaired skeletogenesis, and reverses hypophosphatemia in Phex-deficient mice. , 2004, Matrix biology : journal of the International Society for Matrix Biology.

[121]  D. Miao,et al.  Transgenic mice overexpressing human fibroblast growth factor 23 (R176Q) delineate a putative role for parathyroid hormone in renal phosphate wasting disorders. , 2004, Endocrinology.

[122]  M. Konishi,et al.  Fgf18 is required for embryonic lung alveolar development. , 2004, Biochemical and biophysical research communications.

[123]  D. Ornitz,et al.  Fgf9 signaling regulates inner ear morphogenesis through epithelial-mesenchymal interactions. , 2004, Developmental biology.

[124]  Benjamin R. Arenkiel,et al.  The roles of Fgf4 and Fgf8 in limb bud initiation and outgrowth. , 2004, Developmental biology.

[125]  Zhixiang Liao,et al.  FGF18 Represses Noggin Expression and Is Induced by Calcineurin* , 2004, Journal of Biological Chemistry.

[126]  Gillian M Morriss-Kay,et al.  A gain-of-function mutation of Fgfr2c demonstrates the roles of this receptor variant in osteogenesis. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[127]  C. Tabin,et al.  Evidence for an Expansion-Based Temporal Shh Gradient in Specifying Vertebrate Digit Identities , 2004, Cell.

[128]  C. Ohlsson,et al.  Transgenic mice expressing fibroblast growth factor 23 under the control of the alpha1(I) collagen promoter exhibit growth retardation, osteomalacia, and disturbed phosphate homeostasis. , 2004, Endocrinology.

[129]  Liping Xiao,et al.  Stat1 Controls Postnatal Bone Formation by Regulating Fibroblast Growth Factor Signaling in Osteoblasts* , 2004, Journal of Biological Chemistry.

[130]  T. Doetschman,et al.  Role of Fibroblast Growth Factor-2 Isoforms in the Effect of Estradiol on Endothelial Cell Migration and Proliferation , 2004, Circulation research.

[131]  Y. Takeuchi,et al.  Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism. , 2004, The Journal of clinical investigation.

[132]  T. Yoneya,et al.  FGF-23 transgenic mice demonstrate hypophosphatemic rickets with reduced expression of sodium phosphate cotransporter type IIa. , 2004, Biochemical and biophysical research communications.

[133]  S. Murakami,et al.  Constitutive activation of MEK1 in chondrocytes causes Stat1-independent achondroplasia-like dwarfism and rescues the Fgfr3-deficient mouse phenotype. , 2004, Genes & development.

[134]  Y. Takeuchi,et al.  FGF‐23 Is a Potent Regulator of Vitamin D Metabolism and Phosphate Homeostasis , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[135]  D. Riethmacher,et al.  Requirements for FGF3 and FGF10 during inner ear formation , 2003, Development.

[136]  J. Heath,et al.  Skeletal development is regulated by fibroblast growth factor receptor 1 signalling dynamics , 2003, Development.

[137]  D. Goltzman,et al.  Defective bone mineralization and osteopenia in young adult FGFR3-/- mice. , 2003, Human molecular genetics.

[138]  H. Jüppner,et al.  Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers. , 2003, Kidney international.

[139]  Hiroyuki Tanaka,et al.  Insulin‐like Growth Factor‐1 Rescues the Mutated FGF Receptor 3 (G380R) Expressing ATDC5 Cells From Apoptosis Through Phosphatidylinositol 3‐Kinase and MAPK , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[140]  Haiyang Huang,et al.  Identification of the haematopoietic stem cell niche and control of the niche size , 2003, Nature.

[141]  L. Quarles,et al.  Regulation of Fibroblastic Growth Factor 23 Expression but Not Degradation by PHEX* , 2003, Journal of Biological Chemistry.

[142]  K. White,et al.  FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting. , 2003, The Journal of clinical investigation.

[143]  C. Deng,et al.  A Ser250Trp substitution in mouse fibroblast growth factor receptor 2 (Fgfr2) results in craniosynostosis , 2003 .

[144]  S. Fukumoto,et al.  Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia. , 2003, The New England journal of medicine.

[145]  D. Rice,et al.  Fgfr mRNA isoforms in craniofacial bone development. , 2003, Bone.

[146]  E. Olson,et al.  Conditional inactivation of FGF receptor 2 reveals an essential role for FGF signaling in the regulation of osteoblast function and bone growth , 2003, Development.

[147]  E. Laplantine,et al.  A network of transcriptional and signaling events is activated by FGF to induce chondrocyte growth arrest and differentiation , 2003, The Journal of cell biology.

[148]  T. Doetschman,et al.  Impaired Osteoclast Formation in Bone Marrow Cultures of Fgf2 Null Mice in Response to Parathyroid Hormone* , 2003, Journal of Biological Chemistry.

[149]  H. Ryoo,et al.  The Protein Kinase C Pathway Plays a Central Role in the Fibroblast Growth Factor-stimulated Expression and Transactivation Activity of Runx2* , 2003, The Journal of Biological Chemistry.

[150]  Y. Takeuchi,et al.  Increased circulatory level of biologically active full-length FGF-23 in patients with hypophosphatemic rickets/osteomalacia. , 2002, The Journal of clinical endocrinology and metabolism.

[151]  Andrea Vortkamp,et al.  Interaction of FGF, Ihh/Pthlh, and BMP signaling integrates chondrocyte proliferation and hypertrophic differentiation. , 2002, Developmental cell.

[152]  M. Pines,et al.  The IIIc alternative of Fgfr2 is a positive regulator of bone formation. , 2002, Development.

[153]  S. Mcconnell,et al.  FGFR1 Is Required for the Development of the Auditory Sensory Epithelium , 2002, Neuron.

[154]  T. Yoneya,et al.  Mutant FGF-23 responsible for autosomal dominant hypophosphatemic rickets is resistant to proteolytic cleavage and causes hypophosphatemia in vivo. , 2002, Endocrinology.

[155]  D. Wozniak,et al.  Ataxia and Paroxysmal Dyskinesia in Mice Lacking Axonally Transported FGF14 , 2002, Neuron.

[156]  S. Nishikawa,et al.  Elbow knee synostosis (Eks): a new mutation on mouse Chromosome 14 , 2002, Mammalian Genome.

[157]  P. Marie,et al.  FGF signaling pathways in endochondral and intramembranous bone development and human genetic disease. , 2002, Genes & development.

[158]  R. Berezney,et al.  Integrative nuclear FGFR1 signaling (INFS) pathway mediates activation of the tyrosine hydroxylase gene by angiotensin II, depolarization and protein kinase C , 2002, Journal of neurochemistry.

[159]  D. Ornitz,et al.  Coordination of chondrogenesis and osteogenesis by fibroblast growth factor 18. , 2002, Genes & development.

[160]  E. Wagner,et al.  Reaching a genetic and molecular understanding of skeletal development. , 2002, Developmental cell.

[161]  N. Itoh,et al.  FGF18 is required for normal cell proliferation and differentiation during osteogenesis and chondrogenesis. , 2002, Genes & development.

[162]  Kozo Nakamura,et al.  Regulation of Osteoblast, Chondrocyte, and Osteoclast Functions by Fibroblast Growth Factor (FGF)-18 in Comparison with FGF-2 and FGF-10* , 2002, The Journal of Biological Chemistry.

[163]  C. Deng,et al.  Generation of Fgfr1 conditional knockout mice , 2002, Genesis.

[164]  R. Hayward,et al.  From genotype to phenotype: the differential expression of FGF, FGFR, and TGFbeta genes characterizes human cranioskeletal development and reflects clinical presentation in FGFR syndromes. , 2001, Plastic and reconstructive surgery.

[165]  T. Strom,et al.  Autosomal-dominant hypophosphatemic rickets (ADHR) mutations stabilize FGF-23. , 2001, Kidney international.

[166]  I. Mathijssen,et al.  FGF-4 or FGF-2 administration induces apoptosis, collagen type I expression, and mineralization in the developing coronal suture. , 2001, The Journal of craniofacial surgery.

[167]  D. Ornitz,et al.  Lung hypoplasia and neonatal death in Fgf9-null mice identify this gene as an essential regulator of lung mesenchyme. , 2001, Development.

[168]  C. Deng,et al.  Highly activated Fgfr3 with the K644M mutation causes prolonged survival in severe dwarf mice. , 2001, Human molecular genetics.

[169]  D. Levy,et al.  STAT1 mediates the increased apoptosis and reduced chondrocyte proliferation in mice overexpressing FGF2. , 2001, Development.

[170]  Xiaofeng Li,et al.  Fibroblast Growth Factor Signaling and Basement Membrane Assembly Are Connected during Epithelial Morphogenesis of the Embryoid Body , 2001, The Journal of cell biology.

[171]  S. Takeda,et al.  Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[172]  C. Dickson,et al.  A splicing switch and gain-of-function mutation in FgfR2-IIIc hemizygotes causes Apert/Pfeiffer-syndrome-like phenotypes , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[173]  D. Ornitz,et al.  Male-to-Female Sex Reversal in Mice Lacking Fibroblast Growth Factor 9 , 2001, Cell.

[174]  C. Deng,et al.  A Ser(365)-->Cys mutation of fibroblast growth factor receptor 3 in mouse downregulates Ihh/PTHrP signals and causes severe achondroplasia. , 2001, Human molecular genetics.

[175]  B. Spencer‐Dene,et al.  Fibroblast growth factor receptor 2-IIIb acts upstream of Shh and Fgf4 and is required for limb bud maintenance but not for the induction of Fgf8, Fgf10, Msx1, or Bmp4. , 2001, Developmental biology.

[176]  G. Martin,et al.  Fgf8 signalling from the AER is essential for normal limb development , 2000, Nature Genetics.

[177]  M. Capecchi,et al.  Fgf8 is required for outgrowth and patterning of the limbs , 2000, Nature Genetics.

[178]  S. Vaulont,et al.  Cre-mediated germline mosaicism: a method allowing rapid generation of several alleles of a target gene. , 2000, Nucleic acids research.

[179]  T. Meitinger,et al.  Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23 , 2000, Nature Genetics.

[180]  N. Itoh,et al.  Identification of a novel fibroblast growth factor, FGF-23, preferentially expressed in the ventrolateral thalamic nucleus of the brain. , 2000, Biochemical and biophysical research communications.

[181]  A. Bikfalvi,et al.  Neural and angiogenic defects in eyes of transgenic mice expressing a dominant-negative FGF receptor in the pigmented cells. , 2000, Experimental eye research.

[182]  C. Powers,et al.  Fibroblast growth factors, their receptors and signaling. , 2000, Endocrine-related cancer.

[183]  C. Deng,et al.  A Pro250Arg substitution in mouse Fgfr1 causes increased expression of Cbfa1 and premature fusion of calvarial sutures. , 2000, Human molecular genetics.

[184]  I. Glass,et al.  Clinical findings in a patient with FGFR1 P252R mutation and comparison with the literature. , 2000, American journal of medical genetics.

[185]  C. Deng,et al.  A neonatal lethal mutation in FGFR3 uncouples proliferation and differentiation of growth plate chondrocytes in embryos. , 2000, Human molecular genetics.

[186]  D. Rice,et al.  Integration of FGF and TWIST in calvarial bone and suture development. , 2000, Development.

[187]  D. Ornitz,et al.  Temporal and spatial gradients of Fgf8 and Fgf17 regulate proliferation and differentiation of midline cerebellar structures. , 2000, Development.

[188]  M. Ito,et al.  Disruption of the fibroblast growth factor-2 gene results in decreased bone mass and bone formation. , 2000, The Journal of clinical investigation.

[189]  M. Capecchi,et al.  Normal limb development in conditional mutants of Fgf4. , 2000, Development.

[190]  C. Basilico,et al.  Compensation by Fibroblast Growth Factor 1 (FGF1) Does Not Account for the Mild Phenotypic Defects Observed in FGF2 Null Mice , 2000, Molecular and Cellular Biology.

[191]  B. Spencer‐Dene,et al.  An important role for the IIIb isoform of fibroblast growth factor receptor 2 (FGFR2) in mesenchymal-epithelial signalling during mouse organogenesis. , 2000, Development.

[192]  D. Givol,et al.  Restrained chondrocyte proliferation and maturation with abnormal growth plate vascularization and ossification in human FGFR-3(G380R) transgenic mice. , 2000, Human molecular genetics.

[193]  A. Wilkie,et al.  Fgfr1 and Fgfr2 have distinct differentiation- and proliferation-related roles in the developing mouse skull vault. , 1999, Development.

[194]  C. Deng,et al.  Gly369Cys mutation in mouse FGFR3 causes achondroplasia by affecting both chondrogenesis and osteogenesis. , 1999, The Journal of clinical investigation.

[195]  A. Yayon,et al.  Skeletal Dysplasia and Defective Chondrocyte Differentiation by Targeted Overexpression of Fibroblast Growth Factor 9 in Transgenic Mice , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[196]  K. Ohya,et al.  Anabolic effect of aminoterminally truncated fibroblast growth factor 4 (FGF4) on bone. , 1999, Bone.

[197]  J. Nadeau,et al.  Genomic organization and embryonic expression of the mouse fibroblast growth factor 9 gene , 1999, Developmental dynamics : an official publication of the American Association of Anatomists.

[198]  G. Martin,et al.  Targeted disruption of Fgf8 causes failure of cell migration in the gastrulating mouse embryo. , 1999, Genes & development.

[199]  M. Bamshad,et al.  Severe achondroplasia with developmental delay and acanthosis nigricans (SADDAN): phenotypic analysis of a new skeletal dysplasia caused by a Lys650Met mutation in fibroblast growth factor receptor 3. , 1999, American journal of medical genetics.

[200]  D. Levy,et al.  FGF signaling inhibits chondrocyte proliferation and regulates bone development through the STAT-1 pathway. , 1999, Genes & development.

[201]  C. MacArthur,et al.  Genomic structure, mapping, activity and expression of fibroblast growth factor 17 , 1999, Mechanisms of Development.

[202]  Katsu Takahashi,et al.  Murine fibroblast growth factor receptor 1alpha isoforms mediate node regression and are essential for posterior mesoderm development. , 1999, Developmental biology.

[203]  D. Givol,et al.  A mouse model for achondroplasia produced by targeting fibroblast growth factor receptor 3. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[204]  D. Donoghue,et al.  A novel skeletal dysplasia with developmental delay and acanthosis nigricans is caused by a Lys650Met mutation in the fibroblast growth factor receptor 3 gene. , 1999, American journal of human genetics.

[205]  D. Ornitz,et al.  Repression of hedgehog signaling and BMP4 expression in growth plate cartilage by fibroblast growth factor receptor 3. , 1998, Development.

[206]  D. Danilenko,et al.  Fgf-10 is required for both limb and lung development and exhibits striking functional similarity to Drosophila branchless. , 1998, Genes & development.

[207]  C. Deng,et al.  FGFR-3 and FGFR-4 function cooperatively to direct alveogenesis in the murine lung. , 1998, Development.

[208]  A. Munnich,et al.  Spatio-temporal expression of FGFR 1, 2 and 3 genes during human embryo-fetal ossification , 1998, Mechanisms of Development.

[209]  R. Zeller,et al.  Impaired cerebral cortex development and blood pressure regulation in FGF‐2‐deficient mice , 1998, The EMBO journal.

[210]  J. Rossant,et al.  Opposite phenotypes of hypomorphic and Y766 phosphorylation site mutations reveal a function for Fgfr1 in anteroposterior patterning of mouse embryos. , 1998, Genes & development.

[211]  D. Ornitz,et al.  FGF signaling in skeletal development. , 1998, Frontiers in bioscience : a journal and virtual library.

[212]  M. Evans,et al.  Crouzon‐like craniofacial dysmorphology in the mouse is caused by an insertional mutation at the Fgf3/Fgf4 locus , 1998, Developmental dynamics : an official publication of the American Association of Anatomists.

[213]  G. Martin,et al.  The roles of FGFs in the early development of vertebrate limbs. , 1998, Genes & development.

[214]  S. Tsang,et al.  Neuronal defects and delayed wound healing in mice lacking fibroblast growth factor 2. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[215]  N. Amizuka,et al.  Targeted inactivation of Npt2 in mice leads to severe renal phosphate wasting, hypercalciuria, and skeletal abnormalities. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[216]  J. Heath,et al.  Targeted disruption of fibroblast growth factor (FGF) receptor 2 suggests a role for FGF signaling in pregastrulation mammalian development. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[217]  D. Rice,et al.  FGF-, BMP- and Shh-mediated signalling pathways in the regulation of cranial suture morphogenesis and calvarial bone development. , 1998, Development.

[218]  P. Leder,et al.  Fibroblast growth factor receptor 2 (FGFR2)-mediated reciprocal regulation loop between FGF8 and FGF10 is essential for limb induction. , 1998, Development.

[219]  G. Martin,et al.  An Fgf8 mutant allelic series generated by Cre- and Flp-mediated recombination , 1998, Nature Genetics.

[220]  S. Pawlowski,et al.  Fibroblast growth factor 2 control of vascular tone , 1998, Nature Medicine.

[221]  R. Hayward,et al.  Diversion as a treatment of early postlaryngectomy suprastomal pharyngocutaneous fistula. , 1998 .

[222]  D. Birnbaum,et al.  Apparent normal phenotype of Fgf6-/- mice. , 1997, The International journal of developmental biology.

[223]  J. Rossant,et al.  Chimeric analysis of fibroblast growth factor receptor-1 (Fgfr1) function: a role for FGFR1 in morphogenetic movement through the primitive streak. , 1997, Development.

[224]  T. Kuwana,et al.  The mesenchymal factor, FGF10, initiates and maintains the outgrowth of the chick limb bud through interaction with FGF8, an apical ectodermal factor. , 1997, Development.

[225]  P. Leder,et al.  Fibroblast growth factor receptor-1 (FGFR-1) is essential for normal neural tube and limb development. , 1997, Developmental biology.

[226]  Xin-Yuan Fu,et al.  Activation of Statl by mutant fibroblast growth-factor receptor in thanatophoric dysplasia type II dwarfism , 1997, Nature.

[227]  M. Econs,et al.  Autosomal dominant hypophosphatemic rickets/osteomalacia: clinical characterization of a novel renal phosphate-wasting disorder. , 1997, The Journal of clinical endocrinology and metabolism.

[228]  T. Meitinger,et al.  Pex gene deletions in Gy and Hyp mice provide mouse models for X-linked hypophosphatemia. , 1997, Human molecular genetics.

[229]  C. MacArthur,et al.  Receptor Specificity of the Fibroblast Growth Factor Family* , 1996, The Journal of Biological Chemistry.

[230]  A. Munnich,et al.  Missense FGFR3 mutations create cysteine residues in thanatophoric dwarfism type I (TD1). , 1996, Human molecular genetics.

[231]  Gary W. Harding,et al.  Skeletal overgrowth and deafness in mice lacking fibroblast growth factor receptor 3 , 1996, Nature Genetics.

[232]  P. Leder,et al.  Fibroblast Growth Factor Receptor 3 Is a Negative Regulator of Bone Growth , 1996, Cell.

[233]  A. Mccarthy.  Development , 1996, Current Opinion in Neurobiology.

[234]  E. Fuchs,et al.  Keratinocyte growth factor is required for hair development but not for wound healing. , 1996, Genes & development.

[235]  C. MacArthur,et al.  Roles for FGF8 in the Induction, Initiation, and Maintenance of Chick Limb Development , 1996, Cell.

[236]  B. Olwin,et al.  Changes in the expression of fibroblast growth factor receptors mark distinct stages of chondrogenesis in vitro and during chick limb skeletal patterning , 1995, Developmental dynamics : an official publication of the American Association of Anatomists.

[237]  G. Dorn,et al.  Abnormal bone growth and selective translational regulation in basic fibroblast growth factor (FGF-2) transgenic mice. , 1995, Molecular biology of the cell.

[238]  Paul Martin,et al.  A role for FGF-8 in the initiation and maintenance of vertebrate limb bud outgrowth , 1995, Current Biology.

[239]  I. Kaitila,et al.  Achondroplasia is defined by recurrent G380R mutations of FGFR3. , 1995, American journal of human genetics.

[240]  V. Papaioannou,et al.  Requirement of FGF-4 for postimplantation mouse development , 1995, Science.

[241]  P. Leder,et al.  Murine FGFR-1 is required for early postimplantation growth and axial organization. , 1994, Genes & development.

[242]  J. Rossant,et al.  fgfr-1 is required for embryonic growth and mesodermal patterning during mouse gastrulation. , 1994, Genes & development.

[243]  C. MacArthur,et al.  Fgf-8 expression in the post-gastrulation mouse suggests roles in the development of the face, limbs and central nervous system , 1994, Mechanisms of Development.

[244]  G. Martin,et al.  FGF5 as a regulator of the hair growth cycle: Evidence from targeted and spontaneous mutations , 1994, Cell.

[245]  Arnold Munnich,et al.  Mutations in the gene encoding fibroblast growth factor receptor-3 in achondroplasia , 1994, Nature.

[246]  B. Olwin,et al.  FGF-2: apical ectodermal ridge growth signal for chick limb development. , 1994, Science.

[247]  D. Givol,et al.  Developmental localization of the splicing alternatives of fibroblast growth factor receptor-2 (FGFR2). , 1993, Developmental biology.

[248]  S. Werner,et al.  Unique expression pattern of the FGF receptor 3 gene during mouse organogenesis. , 1993, Developmental biology.

[249]  J. Rossant,et al.  Expression of the fibroblast growth factor receptor FGFR-1/flg during gastrulation and segmentation in the mouse embryo. , 1992, Developmental biology.

[250]  D. Gospodarowicz,et al.  Fibroblast Growth Factor: Involvement in Early Embryonic Development and Ovarian Function , 1989, Critical reviews in oncogenesis.

[251]  K. Lyles,et al.  Correlations of serum concentrations of 1,25-dihydroxyvitamin D, phosphorus, and parathyroid hormone in tumoral calcinosis. , 1988, The Journal of clinical endocrinology and metabolism.

[252]  Harrison He,et al.  Familial hypophosphatemic rickets showing autosomal dominant inheritance. , 1971 .

[253]  S. Murakami,et al.  FGF and ERK signaling coordinately regulate mineralization-related genes and play essential roles in osteocyte differentiation , 2011, Journal of Bone and Mineral Metabolism.

[254]  S. Kliewer,et al.  Fibroblast growth factor 21: from pharmacology to physiology. , 2010, The American journal of clinical nutrition.

[255]  Lin Chen,et al.  FGF signaling: its role in bone development and human skeleton diseases. , 2008, Frontiers in bioscience : a journal and virtual library.

[256]  I. Davis,et al.  Transgenic mice. , 2006, Paediatric respiratory reviews.

[257]  T. Clemens,et al.  Co-ordination of TGF-beta and FGF signaling pathways in bone organ cultures. , 2005, Mechanisms of development.

[258]  K. Nakao,et al.  Overexpression of CNP in chondrocytes rescues achondroplasia through a MAPK-dependent pathway , 2004, Nature Medicine.

[259]  C. Deng,et al.  A Ser252Trp [corrected] substitution in mouse fibroblast growth factor receptor 2 (Fgfr2) results in craniosynostosis. , 2003, Bone.

[260]  N. Endo,et al.  Human PTH (1–34) induces longitudinal bone growth in rats , 2002, Journal of Bone and Mineral Metabolism.

[261]  V. Nurcombe,et al.  Fibroblast growth factor receptor 4 (FGFR4) expression in newborn murine calvaria and primary osteoblast cultures. , 2002, The International journal of developmental biology.

[262]  E. Jabs,et al.  Clinical spectrum of fibroblast growth factor receptor mutations , 1999, Human mutation.

[263]  C. Deng,et al.  A Lys644Glu substitution in fibroblast growth factor receptor 3 (FGFR3) causes dwarfism in mice by activation of STATs and ink4 cell cycle inhibitors. , 1999, Human molecular genetics.

[264]  M M Cohen,et al.  Cephalometric study of the Apert syndrome in adolescence and adulthood. , 1999, Journal of craniofacial genetics and developmental biology.

[265]  Nobuyuki Itoh,et al.  Fgf10 is essential for limb and lung formation , 1999, Nature Genetics.

[266]  R. Hayward,et al.  Fibroblast growth factor receptors are expressed in craniosynostotic sutures. , 1998, Plastic and reconstructive surgery.

[267]  A. Avivi,et al.  Identification of fibroblast growth factor 9 (FGF9) as a high affinity, heparin dependent ligand for FGF receptors 3 and 2 but not for FGF receptors 1 and 4. , 1995, Growth factors.

[268]  D. Johnson,et al.  Structural and functional diversity in the FGF receptor multigene family. , 1993, Advances in cancer research.

[269]  M. Capecchi,et al.  Mice homozygous for a targeted disruption of the proto-oncogene int-2 have developmental defects in the tail and inner ear. , 1993, Development.

[270]  S. Werner,et al.  Two FGF receptor genes are differentially expressed in epithelial and mesenchymal tissues during limb formation and organogenesis in the mouse. , 1992, Development.

[271]  M. Waterfield,et al.  Growth factor receptors. , 1989, British medical bulletin.

[272]  J. Bianchine,et al.  Familial hypophosphatemic rickets showing autosomal dominant inheritance. , 1971, Birth defects original article series.